453 related articles for article (PubMed ID: 3934660)
1. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
Mamolat AS; Bialik IB; Khutorskaia VD
Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
Bialik IB; Klimenko MT
Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942
[No Abstract] [Full Text] [Related]
3. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
4. [Relations between resistance and virulence of mycobacteria].
Daddi G
Arch Monaldi; 1972; 27(4):426-35. PubMed ID: 4217599
[No Abstract] [Full Text] [Related]
5. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
Bialik IB; Klimenko MT
Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
[No Abstract] [Full Text] [Related]
6. [Virulence of polyresistant strains of Mycobacterium tuberculosis].
Drabkina RO; Klimenko MT
Probl Tuberk; 1978 Nov; (11):70-5. PubMed ID: 103091
[No Abstract] [Full Text] [Related]
7. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
Schmelev NA
Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458
[No Abstract] [Full Text] [Related]
8. [Changes in the number and virulence of tubercle bacilli isolated form pulmonary tuberculosis during short course chemotherapy].
Chen SH
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):286-8, 318. PubMed ID: 2128212
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
[No Abstract] [Full Text] [Related]
10. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
Golyshevskaia VI; Akhunov ShB; Bibergal' EA
Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
[No Abstract] [Full Text] [Related]
11. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
Khomenko AG; Chukanov VI; Korneev AA
Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
[TBL] [Abstract][Full Text] [Related]
12. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
Anastasatu C; Moldovan O
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
[No Abstract] [Full Text] [Related]
13. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
Saltini C; Velluti G; Mantovani P
Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
[No Abstract] [Full Text] [Related]
14. Bacteriological bases of short-course chemotherapy.
Grosset J
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):103-7. PubMed ID: 2999945
[No Abstract] [Full Text] [Related]
15. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
Ginzburg TS; Iakimets VP
Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
[No Abstract] [Full Text] [Related]
16. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
Zozuliak VI
Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
[No Abstract] [Full Text] [Related]
17. [Trends in the development of drug resistance in the causative agent of tuberculosis (based on data from an examination of hospital patients)].
Priĭmak AA; Dolzhanskiĭ VM; Sagalovich VIa; El'murzaeva AA
Probl Tuberk; 1985; (8):49-52. PubMed ID: 3932999
[No Abstract] [Full Text] [Related]
18. Modern short-course regimens in the treatment of tuberculosis.
Fox W
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
[No Abstract] [Full Text] [Related]
19. [Formation of a filterable form of the causative agent of tuberculosis in the chemotherapy process (an experimental study)].
Khomenko AK; Golyshevskaia VI; Korolev MB; Drozdov SG
Probl Tuberk; 1982 Mar; (3):50-4. PubMed ID: 6806805
[No Abstract] [Full Text] [Related]
20. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis].
Kartoziia LS
Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
